News
-
-
-
PRESS RELEASE
Oxurion expands its clinical research platform through strategic biometrics partnership between Axiodis CRO and KYomed INNOV
Oxurion NV announces strategic partnership with KYomed INNOV & CEISO for specialist biometrics services in clinical development, aiming to optimize study design and data quality -
-
-
-
PRESS RELEASE
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Oxurion announces EUR 75,000 capital increase with Atlas Special Opportunities, LLC. Company discloses details following issuance of new shares, increasing total outstanding ordinary shares to 140,734,891 -
-
-
PRESS RELEASE
Oxurion achieves another milestone in the expansion of the Exagis platform with the commercial launch of its eTMF module
Oxurion NV launches Exagis eTMF module, a key milestone in building its eClinical software platform. Designed for clinical research efficiency and regulatory compliance
